P4A Let's Talk Rare: The Life Science Podcast
Partners4Access
Welcome to P4A Let’s Talk Rare, a monthly podcast highlighting the most important developments in the world of rare diseases orphan drug, cell and gene therapy, hosted by Georgie Rack and Owen Bryant of Partners For Access. To find out more about Partners For Access and our commitment to sustainable orphan drug access for patients with high unmet need, visit partners4access.com
Kategorier: Videnskab og medicin
Lyt til den sidste episode:
After3 years in the making, the Joint Clinical Assessment for the EU is in effect.
From 12th January 2025 new cancer medicines and advanced therapy medicinal products (ATMPs) will require a JCA across all 27 member states.
Join Owen and Georgie, along with guests Darren Callanan and Sam Morrison to discuss the main talking points of the JCA, and what to look out for when dealing with the new regulations.
Tidligere episoder
-
96 - The JCA is live Mon, 13 Jan 2025
-
95 - Innovative Treatments for Cutaneous T-Cell Lymphoma with Leonard Mazur of Citius Pharmaceuticals  Tue, 19 Nov 2024
-
94 - Amplifying Patient Voices: Wes Michael on Rare Disease Advocacy Thu, 10 Oct 2024
-
93 - Impact of Mergers, Acquisitions, and Patent Expirations on Job Cuts in Pharma and Biotech: Insights from Aurelija Luko and Darren Callanan Tue, 02 Jul 2024
-
92 - The Role of Patient Experience Data in Drug Development with Pina Haberl and Sam Morrison Fri, 03 May 2024
-
91 - World EPA Conference 2024 Special Wed, 10 Apr 2024
-
90 - Rare Disease Day Special 2024: The Role of Genetic Diagnosis in Rare Conditions with Nick Meade  Thu, 29 Feb 2024
-
89 - Celebrating 5 Years of P4A: Reflections on Rare Diseases, Cell and Gene Therapies, and Legislation in Europe Tue, 02 Jan 2024
-
88 - Revolutionizing Patient Outcomes: The Power of Digital Health Solutions with RJ Kedziora  Fri, 01 Dec 2023
-
87 - The Future of Patient Engagement and the Role of Technology in Healthcare with Iola Forster Fri, 06 Oct 2023
-
86 - Navigating the New EU HTA Regulation and Its Impact on ATMP Development Mon, 31 Jul 2023
-
85 - Alejandro Dorenbaum, CMO of Reneo Pharmaceuticals Discusses Clinical-Stage Therapies Thu, 01 Jun 2023
-
84 - Interview with Xortx Therapeutics CEO, Dr Allen Davidoff discussing their journey from early development to potential launch Sat, 29 Apr 2023
-
83 - World EPA Congress 2023 Special Mon, 17 Apr 2023
-
82 - Rare Disease Day Special 2023 Tue, 28 Feb 2023
-
81 - Trends to look out for in 2023 Fri, 03 Feb 2023
-
80 - World Orphan Drug Congress Europe 2022 Special Tue, 20 Dec 2022
-
79 - Winds of change for German Healthcare Market! Mon, 31 Oct 2022
-
78 - Part 2 -Patient Empowerment: Is it a no-brainer?  Mon, 03 Oct 2022
-
77 - Part 1 Patient Empowerment; Why involving patients from early drug development through to launch is a no-brainer! Tue, 13 Sep 2022
-
76 - What makes P4A an award winning consultancy? Fri, 29 Jul 2022
-
75 - Special Episode with EUCOPE-Part 2 with Alexander Natz Thu, 30 Jun 2022
-
74 - Special series with Eucope: Part 1 featuring Victor Maertens Tue, 31 May 2022
-
73 - China market access: obstacle or opportunity for orphan drug, cell and gene therapy manufacturers? Fri, 29 Apr 2022
-
72 - Should the Middle East be a priority launch market for orphan drug manufacturers? Thu, 31 Mar 2022
-
71 - Rare Disease Day Special featuring Janet Bloor and Nick Meade - February 2022 Mon, 28 Feb 2022
-
70 - P4A Insights: Trends to look out for in 2022 Fri, 04 Feb 2022
-
69 - Special episode - Bluebird Bio: What went wrong? -December 2021:  Mon, 13 Dec 2021
-
68 - Special episode featuring James Mackay - November 2021  Tue, 30 Nov 2021
-
67 - Monthly Roundup - October 2021 Fri, 29 Oct 2021
-
66 - Monthly RoundUp - September 2021 Thu, 30 Sep 2021
-
65 - Monthly RoundUp: July 2021 Fri, 30 Jul 2021
-
64 - Monthly RoundUp - June 2021 Wed, 30 Jun 2021
-
63 - Monthly RoundUp - May 2021 Mon, 31 May 2021
-
62 - Weekly RoundUp: August 5, 2019  Mon, 05 Aug 2019
-
61 - Monthly RoundUp - April 2021 Fri, 30 Apr 2021
-
60 - Monthly RoundUp - March 2021 Wed, 31 Mar 2021
-
59 - Monthly RoundUp - February 2021 Sat, 27 Feb 2021
-
58 - Rare Disease Day special episode: Reclaiming the rare disease patient’s voice  Fri, 29 Jan 2021
-
57 - End of year 2020 review  Mon, 21 Dec 2020
-
56 - Special episode: Gene Therapy access from a specialty pharmacy perspective  Mon, 22 Jun 2020
-
55 - Weekly RoundUp: February 29, 2020 Sat, 29 Feb 2020
-
54 - Weekly Roundup: December 30, 2019 Mon, 30 Dec 2019
-
53 - Weekly Roundup: December 23, 2019 Mon, 23 Dec 2019
-
52 - Weekly Roundup: November 12, 2019  Tue, 12 Nov 2019
-
51 - Weekly Roundup: November 5, 2019  Tue, 05 Nov 2019
-
50 - Weekly Roundup: July 29, 2019 Mon, 29 Jul 2019
-
49 - Weekly Roundup: July 22, 2019 Wed, 24 Jul 2019
-
48 - Weekly Roundup: July 1, 2019 Mon, 01 Jul 2019
-
47 - Weekly Roundup: June 23, 2019 Sun, 23 Jun 2019